Search research articles
Contact Us
Filters
Showing results (291-300 of 312) with videos related to
Page
of 32
Sort By:
Nature Communications
|
May 29, 2023
Direct haplotype-resolved 5-base HiFi sequencing for genome-wide profiling of hypermethylation outliers in a rare disease cohort
Warren A Cheung, Adam F Johnson, William J Rowell, et al.
Genome Medicine
|
August 10, 2022
REViewer: haplotype-resolved visualization of read alignments in and around tandem repeats
Egor Dolzhenko, Ben Weisburd, Kristina Ibañez, et al.
Cell Metabolism
|
December 5, 2020
Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in Obesity
Jonathan R Brestoff, Craig B Wilen, John R Moley, et al.
Nature Methods
|
August 4, 2025
The Platinum Pedigree: a long-read benchmark for genetic variants
Zev Kronenberg, Cillian Nolan, David Porubsky, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Synchronized long-read genome, methylome, epigenome, and transcriptome for resolving a Mendelian condition
Mitchell R Vollger, Jonas Korlach, Kiara C Eldred, et al.
Nature Genetics
|
January 29, 2025
Synchronized long-read genome, methylome, epigenome and transcriptome profiling resolve a Mendelian condition
Mitchell R Vollger, Jonas Korlach, Kiara C Eldred, et al.
The New England Journal of Medicine
|
April 22, 2026
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients
Christopher C Butler, Andrew D Pinto, Victoria Harris, et al.
Lancet (London, England)
|
December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 312) with videos related to
Sort By:
Page
of 32
Nature Communications
|
May 29, 2023
Direct haplotype-resolved 5-base HiFi sequencing for genome-wide profiling of hypermethylation outliers in a rare disease cohort
Warren A Cheung, Adam F Johnson, William J Rowell, et al.
Genome Medicine
|
August 10, 2022
REViewer: haplotype-resolved visualization of read alignments in and around tandem repeats
Egor Dolzhenko, Ben Weisburd, Kristina Ibañez, et al.
Cell Metabolism
|
December 5, 2020
Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in Obesity
Jonathan R Brestoff, Craig B Wilen, John R Moley, et al.
Nature Methods
|
August 4, 2025
The Platinum Pedigree: a long-read benchmark for genetic variants
Zev Kronenberg, Cillian Nolan, David Porubsky, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Synchronized long-read genome, methylome, epigenome, and transcriptome for resolving a Mendelian condition
Mitchell R Vollger, Jonas Korlach, Kiara C Eldred, et al.
Nature Genetics
|
January 29, 2025
Synchronized long-read genome, methylome, epigenome and transcriptome profiling resolve a Mendelian condition
Mitchell R Vollger, Jonas Korlach, Kiara C Eldred, et al.
The New England Journal of Medicine
|
April 22, 2026
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients
Christopher C Butler, Andrew D Pinto, Victoria Harris, et al.
Lancet (London, England)
|
December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
Page
of 32